GE HealthCare Technologies Inc. (GEHC) Q4 2025 Earnings Call Transcript
GEHC tops Q4 EPS and revenue estimates as Imaging and PDx drive growth, but net margin slides on tariffs and product mix.
The headline numbers for GE HealthCare (GEHC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.44 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.45 per share a year ago.
GE HealthCare's Allia Moveo wins FDA and CE clearance, enabling commercialization of a mobile C-arm with AI guidance, compact design and early global installs.
GEHC heads into fourth-quarter earnings with steady demand and strong product momentum, though tariffs and investments may keep margins in focus.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for GE HealthCare (GEHC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
The rise of GEHC reflects its strong positioning in imaging, patient monitoring, and pharmaceutical diagnostics.
Medtronic, IQVIA and GE HealthCare show how medical device leaders are turning analytics, AI and enterprise data platforms into recurring revenue engines.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.